20 Years into the Gambia Hepatitis Intervention Study: Assessment of Initial Hypotheses and Prospects for Evaluation of Protective Effectiveness Against Liver Cancer

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-08-0303PMID 18990765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence

  2007cited by this paper
• Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa.

  2006cited by this paper
• Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Ser‐249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa

  2004cited by this paper
• Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms.

  2004cited by this paper
• The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa

  2004cited by this paper
• Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis

  2003cited by this paper
• Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

  2002cited by this paper
• Global control of hepatitis B virus infection.

  2002influential reference
• Cancer in The Gambia: 1988–97

  2001cited by this paper
• What level of hepatitis B antibody is protective?

  1999cited by this paper
• Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age.

  1999cited by this paper
• Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

  1997cited by this paper
• Hepatocellular carcinoma: from gene to public health.

  1997cited by this paper
• Cancer incidence in Conakry, Guinea: first results from the cancer registry 1992–1995

  1997cited by this paper
• Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.

  1995cited by this paper
• Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.

  1993cited by this paper
• Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children.

  1993cited by this paper
• The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B.

  1992cited by this paper
• Aflatoxins isolated by immunoaffinity chromatography from foods consumed in The Gambia, West Africa.

  1992cited by this paper
• Field studies of aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in The Gambia and Thailand.

  1992cited by this paper
• Persistent hepatitis B virus infection and hepatoma in The Gambia, west Africa. A case-control study of 140 adults and their 603 family contacts.

  1992cited by this paper
• Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa.

  1992cited by this paper
• Response to hepatitis B vaccine in relation to the hepatitis B status of family members.

  1991cited by this paper
• Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response.

  1991cited by this paper
• Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.

  1991cited by this paper
• The first 2 years of the Gambian National Cancer Registry.

  1990cited by this paper
• Hepatitis B vaccine in the expanded programme of immunisation: The Gambian experience. The Gambia Hepatitis Study Group.

  1989influential reference
• Hepatitis B vaccine in the Expanded Programme of Immunisation: the Gambian experience.

  1989cited by this paper
• The Gambia Hepatitis Intervention Study. The Gambia Hepatitis Study Group.

  1987influential reference
• DNA hybridisation of cervical smears.

  1985cited by this paper
• Real-time ultrasonography in detection of primary liver cancer in intertropical Africa.

  1985influential reference

• 7-year trend of timely hepatitis B birth dose vaccination coverage in The Gambia: a retrospective, population-based analysis.

  2026cites this paper
• Evaluation of a combined tuberculosis case-finding, treatment and prevention strategy in Thailand: protocol for a pragmatic phase IV stepped-wedge cluster-randomised trial, the CaPThai study.

  2026cites this paper
• Chemoprevention of hepatocellular carcinoma

  2025cites this paper
• Barriers to longitudinal follow-up for hepatitis B treatment in rural Sierra Leone: A mixed methods study of retention in care

  2024cites this paper
• Challenges of hepatitis B treatment in rural Sub‐Saharan Africa: Treatment initiation and outcomes from a public hospital‐based clinic in Kono, Sierra Leone

  2023cites this paper
• Impact of a performance monitoring intervention on the timeliness of Hepatitis B birth dose vaccination in the Gambia: a controlled interrupted time series analysis

  2023cites this paper
• Prevalence of hepatitis B virus infection and effects of service charges on notification among pregnant women attending antenatal care at General Hospital, Otukpo, Nigeria

  2023cites this paper
• Prevalence of hepatitis B infection in the Gambian population: A narrative review of recent developments

  2023cites this paper
• Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients

  2023cites this paper
• The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma

  2022cites this paper
• Hepatitis B Vaccines

  2021cites this paper
• Hepatitis B in the Northern Territory: insights into the changing epidemiology of an ancient condition

  2020cites this paper
• Liver Tumours: The African Perspective

  2020cites this paper
• Population-Based Cancer Registration in Sub-Saharan Africa: Its Role in Research and Cancer Control

  2020cites this paper
• Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia

  2019cites this paper
• Hepatitis B virus sero-prevalence amongst pregnant women in the Gambia

  2019cites this paper
• Effect of Pegylated Interferon Add-On Therapy to Achieve Disease Remission in Patients with Chronic Hepatitis B

  2018cites this paper
• 25 – Hepatitis B Vaccines

  2018cites this paper
• The potential impact of the demographic transition in the Senegal-Gambia region of sub-Saharan Africa on the burden of infectious disease and its potential synergies with control programmes: the case of hepatitis B

  2018cites this paper
• KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians

  2017influential citation
• Hepatitis B virus-associated hepatocellular carcinoma in South Africa: epidemiology and impact of HIV-1 co-infection and immune dysregulation

  2016cites this paper
• Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis.

  2016cites this paper
• Current issues in the design and analysis of stepped wedge trials.

  2015cites this paper
• Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali

  2015cites this paper
• Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

  2015cites this paper
• Prevalence of HBV, HCV and HIV and Anti-HBs Antibodies Positivity in Healthcare Workers in Departments of Surgery in Duhok City, Kurdistan Region, Iraq

  2015cites this paper
• European Code against Cancer 4th Edition: Infections and Cancer.

  2015cites this paper
• Evaluating the Association between HBV Vaccination Coverage and the Incidence of Liver Cancer at a Global Level

  2015cites this paper
• Establishing Translational and Clinical Cancer Research Collaborations Between High- and Low-Income Countries

  2015cites this paper
• Hepatitis B virus epidemiology.

  2015cites this paper
• Cancer prevention in Africa: a review of the literature

  2015influential citation
• Use of vaccines as probes to define disease burden.

  2014cites this paper
• Building capacity for sustainable research programmes for cancer in Africa

  2014cites this paper
• Population-Based Interventions to Reduce the Public Health Burden Related with Hepatitis B Virus Infection in The Gambia, West Africa

  2014cites this paper
• Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986–90) and in the nationwide immunisation program

  2014cites this paper
• No Patients to Resect or Transplant: An Analysis of Patients with Hepatocellular Carcinoma Admitted to a Major African Referral Hospital

  2014cites this paper
• 20-Years of Population-Based Cancer Registration in Hepatitis B and Liver Cancer Prevention in The Gambia, West Africa

  2013cites this paper
• Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011.

  2013cites this paper
• 15 – Hepatitis B vaccines

  2013cites this paper
• The molecular epidemiology of hepatitis B in the Indigenous people of northern Australia

  2013cites this paper
• Control of viral hepatitis infection in Africa: are we dreaming?

  2013cites this paper
• Global geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwide

  2013cites this paper
• The impact of hepatitis B vaccine in China and in the China GAVI Project.

  2013cites this paper
• Clinical Epidemiological Characterization of Acute Liver Failure

  2012cites this paper
• TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.

  2012cites this paper
• Impact of Universal Vaccination Against Hepatitis B: The Italian Model

  2012cites this paper
• Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa.

  2012cites this paper
• Viral hepatitis: global goals for vaccination.

  2012cites this paper
• Hepatitis B: Epidemiology and prevention in developing countries.

  2012cites this paper
• Hepatitis A: Epidemiology and prevention in developing countries.

  2012cites this paper
• A million africans a year dying from cancer by 2030: What can cancer research and control offer to the continent?

  2012influential citation
• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns

  2012cites this paper
• Prevention of Hepatocellular Carcinoma: Vaccination and Dietary Changes Show Promise to Eliminate Most Cases of Human Liver Cancer

  2012cites this paper
• HEPATITIS B VIRUS The hepatitis

  2012cites this paper
• CHAPTER 11 – Tropical Infectious Diseases and Malignancy

  2011cites this paper
• Preventing primary liver cancer: the HBV vaccination project in the Gambia (West Africa)

  2011cites this paper
• The cancer burden and cancer control in developing countries

  2011cites this paper
• Clinical trials of cancer screening in the developing world and their impact on cancer healthcare.

  2011cites this paper
• Hepatitis B and the need for a booster dose.

  2011influential citation
• Increase in Female Liver Cancer in The Gambia, West Africa: Evidence from 19 Years of Population-Based Cancer Registration (1988–2006)

  2011cites this paper
• Evaluation of Large-Scale Combination HIV Prevention Programs: Essential Issues

  2011cites this paper
• Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians

  2010cites this paper
• Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme

  2010cites this paper
• Prevention trials: their place in how we understand the value of prevention strategies.

  2010cites this paper
• Evaluation of a hepatitis B vaccination program in Taiwan: impact on hepatocellular carcinoma development.

  2010cites this paper
• Epidemiology of hepatitis B and C viruses: a global overview.

  2010cites this paper
• Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.

  2010cites this paper
• Molecular pathogenesis and early detection of hepatocellular carcinoma--perspectives from West Africa.

  2009cites this paper
• Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention.

  2009cites this paper
• Cooperation of tumor‐derived HBx mutants and p53‐249ser mutant in regulating cell proliferation, anchorage‐independent growth and aneuploidy in a telomerase‐immortalized normal human hepatocyte‐derived cell line

  2009cites this paper
• puBlICatIons du personnel du CIrC 2008-2009

  2009cites this paper
• CHAPTER 107 Liver Tumours

  2008cites this paper
• Hepatitis B Virus

  year unknowncites this paper